Sialomucins are a heterogeneous group of secreted or membrane-associated mucins that appear to play two key but opposing roles in vivo: first as cytoprotective or antiadhesive agents, and second as adhesion receptors. CD164 is a type I integral transmembrane sialomucin that functions as an adhesion receptor.
A genome wide CRISPR/Cas9 screen in human A549 cells identified CD164 as an internal entry receptor for the arenavirus Lymphocytic Choriomeningitis Virus (LCMV).